Top Industry Leaders in the Oral Doxycycline Hyclate Market
Teva Pharmaceuticals (Israel) Acquired Actavis, gaining access to doxycycline hyclate products and strengthening its position in the generics market.
Sun Pharma (India) Launched Doxicaps Plus, a doxycycline-clavulanate potassium combination product for treating antibiotic-resistant bacterial infections.
Lupin (India) Received FDA approval for its doxycycline hyclate delayed-release capsules, offering a potential solution to gastrointestinal side effects.
Alkem Laboratories (India) Partnered with Cipla to expand marketing and distribution of doxycycline hyclate products in Africa.
Pfizer (US) Continues to hold a significant market share with its branded formulation of doxycycline, Vibramycin.
List of Oral Doxycycline Hyclate Key Companies in the Market
- Zydus Pharmaceuticals
- G&W Laboratories
- Ajanta Pharma
- Amneal Pharmaceuticals
- Prinston Pharmaceutical
- Alembic Pharmaceuticals
- Novel Laboratories
- Emcure
- Teva
- Heritage Pharmaceuticals
- Almirall
- Mayne Pharma
- Par Pharmaceutical
- Sun Pharmaceutical
- Mylan